Literature DB >> 1930337

Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus.

M H Liang1, A J Partridge, L H Daltroy, K V Straaton, S R Galper, H R Holman.   

Abstract

The epidemiology of systemic lupus erythematosus suggests that the excess morbidity and mortality in blacks with the disease is related to lower socioeconomic status. Poverty and factors associated with poverty are powerful predictors of poor outcome in a variety of chronic diseases, and lupus appears to be no exception. A body of studies in other illnesses suggests ways to neutralize, at least partially, the disadvantages of lower socioeconomic status, even though the root causes of poverty may be insurmountable. These include improving access to quality health care; targeting educational programs to promote recognition and understanding of the disease and the comorbid conditions that affect outcome; implementing programs to improve self-monitoring and adherence to medical regimens; developing opportunities to facilitate homemaking, childrearing, and working outside the home; and applying psychosocial interventions to enhance self-confidence and social support. Improved access to quality health care may actually lead to a decrease in health care costs.

Entities:  

Mesh:

Year:  1991        PMID: 1930337     DOI: 10.1002/art.1780340918

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

1.  Ethnicity and mortality from systemic lupus erythematosus in the US.

Authors:  E Krishnan; H B Hubert
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

2.  Demographic, autoimmune, and clinical profiles of patients with systemic lupus erythematosus in Oman.

Authors:  M H Al-Maini; E M El-Ageb; S S Al-Wahaibi; Y Al-Farsi; E R Richens
Journal:  Rheumatol Int       Date:  2003-04-02       Impact factor: 2.631

Review 3.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments.

Authors:  Cindy H Flower; Anselm J M Hennis; Matthew H Liang
Journal:  Curr Rev Musculoskelet Med       Date:  2011-09

5.  Factors Associated with the Initiation and Retention of Patients with Lupus in the Chronic Disease Self-Management Program.

Authors:  Titilola Falasinnu; Gaobin Bao; Teresa J Brady; S Sam Lim; Cristina Drenkard
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-11-04       Impact factor: 5.178

Review 6.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

7.  Atherosclerotic vascular disease in systemic lupus erythematosus.

Authors:  Matthew H Liang; Lisa A Mandl; Karen Costenbader; Ervin Fox; Elizabeth Karlson
Journal:  J Natl Med Assoc       Date:  2002-09       Impact factor: 1.798

Review 8.  Disparities in lupus care and outcomes.

Authors:  Kristina L Demas; Karen H Costenbader
Journal:  Curr Opin Rheumatol       Date:  2009-03       Impact factor: 5.006

9.  Social Support and Self-Reported Stress Levels in a Predominantly African American Sample of Women with Systemic Lupus Erythematosus.

Authors:  Edith Marie Williams; Jiajia Zhang; Judith Anderson; Larisa Bruner; Laurene Tumiel-Berhalter
Journal:  Autoimmune Dis       Date:  2015-09-09

Review 10.  I too, am America: a review of research on systemic lupus erythematosus in African-Americans.

Authors:  Edith M Williams; Larisa Bruner; Alyssa Adkins; Caroline Vrana; Ayaba Logan; Diane Kamen; James C Oates
Journal:  Lupus Sci Med       Date:  2016-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.